Hereditary Angioedema News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Hereditary Angioedema - Epidemiology Forecast to 2025 - PR Newswire (press release)



Hereditary Angioedema - Epidemiology Forecast to 2025 
PR Newswire (press release)
NEW YORK, Nov. 17, 2017 /PRNewswire/ -- DelveInsight's "Hereditary Angioedema -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Hereditary Angioedema in seven major markets (US, France, Germany, Italy, Spain, UK ...

and more » 


VIDEO: New treatment developments on the horizon for acute hereditary angioedema - Healio



Healio
 
VIDEO: New treatment developments on the horizon for acute hereditary angioedema 
Healio
BOSTON ? The landscape of hereditary angioedema and how it is diagnosed, assessed and treated has been ever-evolving and will continue to change as new treatment options for the rare disorder are identified, according to Michael E. Manning, MD, ...

 


Haegarda Shows 98% Median Reduction in Hereditary Angioedema Attacks Per Month in Study - P&T Community



Haegarda Shows 98% Median Reduction in Hereditary Angioedema Attacks Per Month in Study 
P&T Community
A phase 3 trial has demonstrated that, at the approved dose of 60 IU/kg, Haegarda (C1 esterase inhibitor subcutaneous [human]) reduced the median number of hereditary angioedema (HAE) attacks per month by 98% in patients who had frequent attacks, ...

and more » 


Hereditary Angioedema Market Insights, Epidemiology and Forecast 2025 - Research of Market



Hereditary Angioedema Market Insights, Epidemiology and Forecast 2025 
Research of Market
Hereditary Angioedema-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Hereditary Angioedema. The report provides a complete understanding of the pipeline ...

and more » 


Hereditary Angioedema Market ? Expected to rise at a remarkable CAGR By 2025 - MilTech



MilTech
 
Hereditary Angioedema Market ? Expected to rise at a remarkable CAGR By 2025 
MilTech
According to the top market research analysts, the Hereditary Angioedema market to grow steadily at a high CAGR value from 2015 to 2025. This research report will help in enhanced understanding of the Hereditary Angioedema market from inside out, with ...

and more » 


BRIEF?CSL Behring presents positive data for hereditary angioedema therapy - The Pharma Letter



Rare Disease Report
 
BRIEF?CSL Behring presents positive data for hereditary angioedema therapy 
The Pharma Letter
Australia's CSL Behring has presented positive data on hereditary angioedema (HAE) therapy Haegarda (C1 esterase inhibitor). The data show Haegarda reduced the median number of HAE attacks per month by 98% in subjects who had frequent attacks, ...
Haegarda Reduces HAE Attacks by 98% in Most Severe Cases Rare Disease Report (blog)

all 3 news articles » 


Hereditary Angioedema Market 2017 Review and Forecast 2017 - satPRnews (press release)



Hereditary Angioedema Market 2017 Review and Forecast 2017 
satPRnews (press release)
ReportsWeb.com has announced the addition of the ?Global Hereditary Angioedema Industry Market Research Report 2017-2021? The report focuses on global major leading industry players with information such as company profiles, product picture and ...

and more » 


Repeal of Orphan Drug Tax Credit is an "Unprecedented Step" - PR Newswire (press release)



NPR
 
Repeal of Orphan Drug Tax Credit is an "Unprecedented Step" 
PR Newswire (press release)
... protein therapies are life-saving treatments for persons facing particularly rare conditions, including Primary Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, bleeding disorders such as Hemophilia, Hereditary ...
NORD Issues Statement in Response to Proposed Repeal of the Orphan Drug Tax Credit National Organization for Rare Disorders

all 8 news articles » 


BioCryst Announces Late Breaker Presentation of BCX7353 Phase 2 APeX-1 Trial Results at the ACAAI's 2017 Annual ... - GlobeNewswire (press release)



BioCryst Announces Late Breaker Presentation of BCX7353 Phase 2 APeX-1 Trial Results at the ACAAI's 2017 Annual ... 
GlobeNewswire (press release)
RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that results from its successful Phase 2 APeX-1 clinical trial in hereditary angioedema (HAE) will be presented at ...

and more » 


Fit City picks for weekend fun - austin360 (blog)



austin360 (blog)
 
Fit City picks for weekend fun 
austin360 (blog)
HAE In-Motion 5K ? Help raise scholarship money by participating in this small 5K race that raises awareness about hereditary angioedema, or HAE. The rare and potentially life-threatening condition occurs in one in 50,000 people, causing spontaneous ...

and more »